The estimated Net Worth of Daniel A Welch is at least $102 Thousand dollars as of 14 March 2017. Daniel Welch owns over 5,000 units of Phibro Animal Health stock worth over $102,250 and over the last 11 years Daniel sold PAHC stock worth over $0.
Daniel has made over 8 trades of the Phibro Animal Health stock since 2014, according to the Form 4 filled with the SEC. Most recently Daniel exercised 5,000 units of PAHC stock worth $59,150 on 14 March 2017.
The largest trade Daniel's ever made was exercising 5,000 units of Phibro Animal Health stock on 14 March 2017 worth over $59,150. On average, Daniel trades about 3,556 units every 91 days since 2014. As of 14 March 2017 Daniel still owns at least 5,000 units of Phibro Animal Health stock.
You can see the complete history of Daniel Welch stock trades at the bottom of the page.
Daniel's mailing address filed with the SEC is 300 FRANK W. BURR BLVD., STE 21, , TEANECK, NJ, 07666-6712.
Over the last 11 years, insiders at Phibro Animal Health have traded over $195,476,671 worth of Phibro Animal Health stock and bought 26,000 units worth $514,940 . The most active insiders traders include L.P. Mayflower, Co., Llc Bfi, and Jack Bendheim. On average, Phibro Animal Health executives and independent directors trade stock every 17 days with the average trade being worth of $962,991. The most recent stock trade was executed by E Thomas Corcoran on 4 September 2024, trading 5,000 units of PAHC stock currently worth $100,100.
phibro animal health corporation is a leading global diversified animal health and mineral nutrition company. we are dedicated to helping meet the growing demand for animal protein. we concentrate exclusively on animals for food production and are one of the few global companies offering a comprehensive range of animal health and mineral nutrition products. for over 40 years we have been committed to providing livestock producers with value-based products and solutions to help them maintain and enhance the health of their animals. we develop, manufacture and market a broad range of products for food animals including poultry, swine, beef and dairy cattle and aquaculture. our products help prevent, control and treat diseases, enhance nutrition to help improve health and contribute to balanced mineral nutrition. phibro animal health corporation reported net sales of $764 million for the fiscal year ended june 30, 2017. our more than 1,400 employees are proud to manufacture and market our
Phibro Animal Health executives and other stock owners filed with the SEC include: